BPC-157 and Nasal Delivery Despite mounting research on nasal peptide administration, studies on nasal delivery of BPC-157 are lacking
AOD 9604 is best understood as a metabolic adjunct rather than a standalone fix, which means it is designed to support fat loss efforts, not replace them
Medical supervision ensures: Appropriate screening Proper dosing Monitoring for side effects Clear expectations Foundational Recovery Still Matters Whether or not you explore peptide therapy, your recovery depends heavily on the basics: Adequate protein intake (1.2 to 1.6 grams/kg of body weight) Proper hydration (drink fluids throughout the day, regularly check the color of your urine) Quality sleep (if sleep hygiene tactics dont work, address psychological and physiological factors)
The peptide has an arginine in place of glutamic acid at position 3, and an extra 13-amino-acid extension on the front (the N-terminus ), making the full chain 83 amino acids instead of native IGF-1's 70
If not, the substance remains outside the compounding framework